Zacks Analyst Blog Highlights: Sanderson Farms, ViroPharma, Allion Healthcare Inc., Nordstrom Inc. and Developers Diversified.

Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Sanderson Farms (NASDAQ: SAFM), ViroPharma (NASDAQ: VPHM), Allion Healthcare Inc. (NASDAQ: ALLI), Nordstrom Inc. (NYSE: JWN) and Developers Diversified (NYSE: DDR).

Get the most recent insight from Zacks Equity Research with the free Profit from the Pros newsletter: http://at.zacks.com/?id=4579

Here are highlights from Tuesday’s Analyst Blog:

Sanderson Farms Stays Plucky

Sanderson Farms (NASDAQ: SAFM) is the 4th largest poultry processing company in the U.S. The improved efficiencies at the company's poultry complexes in Georgia and Mississippi, along with the new facility in Waco, Texas, should improve unit operating costs and increase production levels in fiscal 2009.

However, grain costs increased substantially in fiscal 2008 resulting in a loss. Even though grain prices have declined, the Hold rating is maintained.

ViroPharma's Phase 3 Setback

This morning, ViroPharma (NASDAQ: VPHM) announced that its phase III trial evaluating maribavir as a prophylaxis in allogenic stem cell, or bone marrow, transplant (SCT) patients did not achieve its primary endpoint of a reduction in cytomegalovirus (CMV) disease within 6 months.

We are clearly disappointed in the outcome of the phase III maribavir SCT trial. Maribavir was key to our investment thesis given the expected launch of a generic Vancocin product potentially during the second half of 2009.

Buy Allion Healthcare Up to $6

Allion Healthcare Inc. (NASDAQ: ALLI) is a national provider of specialty pharmacy and disease management services focused on HIV/AIDS patients. We expect ALLI to report 4Q08 financial results on March 11, 2009.

Our current revenue and EPS estimates are $92M and $0.11 respectively, versus consensus estimates of $93M and $0.12. Our Buy recommendation remains intact at current levels pending the 4Q08 earnings release.

Nordstrom Upgraded Pre-Earnings

Seattle-based specialty retailer Nordstrom Inc. (NYSE: JWN) operates a chain of department and outlet stores. We are upgrading Nordstrom shares from Sell to Hold.

We think that the federal government's stimulus package could lead to an explosive rally in JWN shares. This is not to say that we have become more bullish on Nordstrom or retailers in general; we have not. We continue to believe that consumer discretionary spending will not return to the levels of the last several years.

DDR Continues to De-Lever

Developers Diversified (NYSE: DDR) announced more assets sales today. The company sold 5 Mervyn’s locations and one shopping center in Florida. Net proceeds from the shopping sale will be about $22 million to DDR. DDR has another $100 million of property under contract or LOI [letter of intent].

The company has now paid back all of its unsecured notes due in 2009. DDR only has $198 million of wholly owned and JV [joint-venture] property level mortgage debt maturing in 2009. 2010 debt maturities, excluding extension options, are over $1.2 billion and DDR still has too much debt, about $7 billion in total.

Want more from Zacks Equity Research? Subscribe to the free Profit from the Pros newsletter: http://at.zacks.com/?id=2649.

About Zacks Equity Research

Zacks Equity Research provides the best of quantitative and qualitative analysis to help investors know what stocks to buy and which to sell for the long-term.

Continuous coverage is provided for a universe of 1,150 publicly traded stocks. Our analysts are organized by industry which gives them keen insights to developments that affect company profits and stock performance. Recommendations and target prices are six-month time horizons.

Zacks "Profit from the Pros" e-mail newsletter provides highlights of the latest analysis from Zacks Equity Research. Subscribe to this free newsletter today: http://at.zacks.com/?id=2677

About Zacks

Zacks.com is a property of Zacks Investment Research, Inc., which was formed in 1978 by Leonard Zacks. As a PhD in mathematics Len knew he could find patterns in stock market data that would lead to superior investment results. Amongst his many accomplishments was the formation of his proprietary stock picking system; the Zacks Rank, which continues to outperform the market by nearly a 3 to 1 margin. The best way to unlock the profitable stock recommendations and market insights of Zacks Investment Research is through our free daily email newsletter; Profit from the Pros. In short, it's your steady flow of Profitable ideas GUARANTEED to be worth your time! Register for your free subscription to Profit from the Pros at http://at.zacks.com/?id=4580.

Visit http://www.zacks.com/performance for information about the performance numbers displayed in this press release.

Disclaimer: Past performance does not guarantee future results. Investors should always research companies and securities before making any investments. Nothing herein should be construed as an offer or solicitation to buy or sell any security.

Contacts:

Zacks.com
Mark Vickery
Web Content Editor
312-265-9380
Visit: www.zacks.com

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.